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Background: Transdermal drug delivery has several advantages and has been vastly investigated over the last decades. Chemical 
enhancers improve the quantity of drug penetration through the skin.
Objectives: In this study, some conventional solvents and surfactants were used as enhancers to promote dermal penetration of 
α-hydroxyacids (AHA) and hyaluronic acid (HA).
Materials and Methods: A total of 42 different formulations containing AHA or HA as the active ingredient and a solvent or surfactant 
as the enhancer were prepared. The experiments for determination of transdermal absorption of AHA or HA for each formulation were 
performed using a diffusion cell and a slice of chicken skin as model at 32℃. After 1.5 or 12 hours, samples from the medium were collected 
and analyzed for AHA or HA concentration.
Results: After 1.5 and 12 hours, the maximum permeated amount of AHA were 89.8 and 342.5 mg, respectively, which related to the 
formulations with liquid paraffin. After 1.5 and 12 hours, the maximum permeated amount of HA were 57.3 and 70.6 mg, respectively, 
which related to the formulations with glycerol.
Conclusions: The most effective enhancer for AHA and HA were liquid paraffin and glycerol, respectively. The most effective surfactant for 
both AHA and HA was Tween 80. The effects of the enhancers were increased by prolonging the exposure time.
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1. Background
Hyaluronic acid (HA) is a macromolecule used in topi-
cal pharmaceutical and cosmetic preparations. It is 
useful in wounds healing and wrinkles smoothing. The 
size of HA (approximately 200 kDa) may limit its free dif-
fusion following topical administration. On the other 
hand, injections are painful and may need repeating (1). 
Advances in transdermal drug delivery offer a less inva-
sive way of drug administration (1). Fortunately, stud-
ies suggest that efficient topical delivery of HA depends 
on the penetration enhancement strategies (2). One 
aim of the present study was to find the appropriate 
enhancers for topical delivery of HA. Transdermal deliv-
ery systems have been rather beneficial for the delivery 
of small drug molecules (1). Other widely used drugs 
in topical antiaging products are small molecules of 
α-Hydroxy acids (AHA). We aimed to find some enhanc-
ers that improve skin penetration of both AHA and HA. 
Development of transdermal products is restricted by 
the low permeability of the skin. To overcome this prob-
lem, numerous chemicals have been employed as skin 
permeation enhancers (3). Several groups of enhanc-
ers have been introduced including certain peptides, 
hydrophobic nanoparticles, surfactants, and solvents 
(3, 4). In the present study, 12 conventional hydrophil-
ic and hydrophobic solvents, which have been widely 
investigated in the present literature, were selected to 
explore their effect on skin permeation of HA as well 
as AHA. In addition, four surfactants with completely 
different chemical structures were evaluated for their 
potentials as enhancers. It is known that hydrophilic 
molecules have difficulties for transdermal absorption 
in comparison with hydrophobic molecules. There-
fore, the hydrophilic structure of both HA and AHA can 
highlight their need for using dermal absorption en-
hancers. For the skin penetration experiments, in vitro 
method was chosen. The use of in vitro models is also 
supported by the fact that stratum corneum (SC), the 
principle site of enhancer action, presents similar be-
havior in vivo and in vitro (5, 6).
2. Objectives
The objective of the study was to evaluate different 
chemical substances for their ability to enhance the skin 
delivery of two active ingredients including: Hydroxy Ac-
ids and Hyaluronic Acid.
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Table 1.  Formulations 1 Through 17 and Their Constituents a,b
Formulation Number Enhancer Exposure Time, h Permeated AHA, mg
1 DW, 2 mL 1.5 46.0
2 DW, 6 mL 12 298.2
3 Acetic acid (1M), 2 mL 1.5 48.0
4 Acetic acid (1M), 6 mL 12 108.1
5 Methanol, 2 mL 1.5 38.9
6 Ethanol, 2 mL 1.5 53.2
7 Ethanol, 6 mL 12 274.1
8 IPA, 2 mL 1.5 64.9
9 Glycerol, 2 mL 1.5 70.0
10 Glycerol, 6 mL 12 315.5
11 PG, 2 mL 1.5 54.9
12 EA, 2 mL 1.5 64.7
13 THF, 2 mL 1.5 56.4
14 DMSO, 2 mL 1.5 59.3
15 LP, 2 mL 1.5 89.8
16 LP, 6 mL 12 342.5
17 Olive oil, 2mL 1.5 51.6
a Abbreviations: AHA, α-hydroxyacids; DW, deinoized water; IPA, isopropyl alcohol; PG, propylene glycol; EA, ethyl acetate; THF, tetrahydrofurane; 
DMSO, dimethyl sulfoxide; and LP, liquid paraffin.
b All formulations contained 500 mg of α-hydroxyacids.
Table 2.  Formulations 18 Through 21 and Their Constituents a,b
Formulation Number Enhancer Exposure Time, h Permeated AHA, mg
18 SLS, 500 mg 1.5 41.5
19 Tween 80, 500 mg 1.5 49.0
20 Glycine, 500 mg 1.5 46.3
21 Albumin, 500 mg 1.5 15.3
a Abbreviations: AHA, α-hydroxyacids; and SLS, sodium lauryl sulfate.
b All formulations contained 500 mg of α-hydroxyacids and 2 mL of DW.
Table 3.  Formulations 22 through 38 and Their Constituents a,b
Formulation Number Enhancer Exposure Time, h Permeated AHA, mg
22 DW, 2 mL 1.5 0.3
23 DW, 6 mL 12 26.9
24 Acetic acid (1M), 2 mL 1.5 5.8
25 Acetic acid (1M), 6 mL 12 34.1
26 Methanol, 2 mL 1.5 4.1
27 Ethanol, 2 mL 1.5 8.2
28 Ethanol, 6 mL 12 18.7
29 IPA, 2 mL 1.5 23.4
30 Glycerol, 2 mL 1.5 57.3
31 Glycerol, 6 mL 12 70.6
32 PG, 2 mL 1.5 11.5
33 EA, 2 mL 1.5 0.3
34 THF, 2 mL 1.5 0.2
35 DMSO, 2 mL 1.5 2.1
36 LP, 2 mL 1.5 23.2
37 LP, 6 mL 12 31.8
38 Olive oil, 2 mL 1.5 6.5
a Abbreviations: AHA, α-hydroxyacids, DW, deionized water, IPA, isopropyl alcohol; PG, propylene glycol; EA, ethyl acetate; THF, tetrahydrofurane; DMSO, 
dimethyl sulfoxide; and LP, liquid paraffin.
b All formulations contained 500 mg of α-hydroxyacids and 2 mL of DW.
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Table 4.  Formulations 39 Through 42 and Their Constituentsa,b
Formulation Number Enhancer Exposure Time, h Permeated AHA, mg
39 SLS, 500 mg 1.5 7.7
40 Tween 80, 500 mg 1.5 8.1
41 Glycine, 500 mg 1.5 0.5
42 Albumin, 500 mg 1.5 0.4
a Abbreviations: AHA, α-hydroxyacids; and SLS, sodium lauryl sulfate.
b All formulations contained 500 mg of α-hydroxyacids and 2 mL of DW.
3. Materials and Methods
AHA (lactic acid), HA, liquid paraffin (LP), acetic acid, 
ethyl acetate (EA), methanol, ethanol, isopropyl alcohol 
(IPA), glycerol, propylene glycol (PG), tetrahydrofurane 
(THF), dimethyl sulfoxide (DMSO), olive oil, sodium lau-
ryl sulfate (SLS), glycine, and human serum albumin were 
purchased from Sigma-Aldrich company, USA.
3.1. Preparation of Formulations
Every formulation, i.e. formulations 1 through 42, were 
prepared via mixing 500 mg of AHA or HA, as the active 
ingredient, with 2 mL of each solvent (listed in Tables 1 
and 3) or 500 mg of each surfactant (listed in Tables 2 and 
4) as the enhancer, using a mechanical overhead mixer 
(Heidolph, RZR 2020, Germany) at 3000 rpm for 20 min-
utes. Mixing was continued to make a lotion.
3.2. Permeation Test
The transdermal penetration of AHA or HA was deter-
mined by a diffusion cell with an effective diffusion area 
of 10 cm2 with a glass cap. Its 30 mL volume receiver 
chamber was filled with phosphate-buffered saline (PBS). 
An isolated piece of skin of a three-month-old chicken 
was fixed between two chambers as the diffusional mem-
brane, making an almost stretched skin. Isolated skins 
were carefully selected in order to have low underlying 
fat tissue. They were accurately selected in order to be 
completely similar in terms of thickness of fat tissue and 
the number of hair follicles. Each formulation was placed 
and spread on the skin. Then the cap (donor chamber) 
was placed and fixed on that to avoid evaporation. The 
cell was placed in a shaker-incubator (Heidolph Incuba-
tor 1000, Heidolph Co., Germany) with a temperature of 
32℃ for three hours (3, 21). The cap was taken away every 
15 minutes and the lotion was rubbed evenly by a swab to 
help the active ingredient penetration. Three milliliters 
of PBS was taken after exposure time of 1.5 hours (or 12 
hours for formulations 2, 4, 7, 10, 16, 23, 25, 28, 31, and 37) 
and analyzed for the concentration of AHA at 210 nm or 
for HA at 260 nm, using a UV-Vs spectrophotometer (Per-
kin-Elmer-Lambda25, USA). For the formulations contain-
ing 6 mL of the related solvent (formulations 2, 4, 7, 10, 16, 
23, 25, 28, 31, and 37), 2 mL of the solvent was added during 
preparation of the formulation (like the other formula-
tions with 2 mL of solvent); after three and six hours of 
incubation, 2 mL of the solvent was added to the formula-
tion on the skin after each incubation time, i.e. a total of 
6 mL for each mentioned formulation.
3.3. Statistical Analysis
Each formulation was tested three times for AHA or HA 
permeation and the data were reported as mean ± SD (n 
= 3). One-way analysis of variance (ANOVA) was used for 
comparing the mean differences. SPSS for Windows (ver-
sion 11.5.0, SPSS Inc., Chicago, IL, USA) was employed for 
statistical analysis. P < 0.05 was considered significant.
4. Results
Permeability experiments resulted in permeation of 
about 40 to 90 mg AHA through the skin during 1.5 hours 
by formulations 1, 3, 5, 6, 8, 9, 11, 12, 13, 14, 15, and 17, while 
each formulation contained 2 mL of the related solvent. 
During 12 hours, the AHA permeation of about 298, 108, 
274, 315, and 342 mg by formulations 2, 4, 7, 10, and 16 
was achieved, while each formulation contained 6 mL 
of the related solvent. Permeation of AHA was about 15 
to 50 mg during 1.5 hours by formulations 18 through 21, 
while each formulation contained 500 mg of the related 
surfactant. In case of formulations containing HA, results 
showed HA permeation of 0.2 to 57.3 mg during 1.5 hours 
by formulations 22, 24, 26, 27, 29, 30, 32, 33, 34, 35, 36, and 
38, each containing 2 mL of the related solvent. Results 
also showed HA permeation of 18.7 to 70.6 mg during 12 
hours by formulations 23, 25, 28, 31, and 37, each contain-
ing 6 mL of the related solvent. Permeation of HA was 0.4 
to 8.1 mg during 1.5 hours by formulations 39 through 42, 
each containing 500 mg of the related surfactant. Figures 
1 and 2 show permeation of AHA through the skin from 
different formulations after 1.5 hours, and Figure 3 shows 
similar data after 12 hours. Using solvents as permeation 
enhancers (Figure 1), the maximum permeation during 
1.5 hours belonged to the formulations 15 and 9 (89.8 mg 
with 2 mL of LP and 70 mg with glycerol, respectively) 
(P < 0.05). The minimum permeation during 1.5 hours 
belonged to the formulation 5 (about 39 mg) (P < 0.05) 
containing 2 mL of methanol. Other solvents lead to per-
meations between these amounts with a maximum of 
about 65 mg (P < 0.05). In case of using surfactants as per-
meation enhancers (Figure 2), the maximum AHA perme-
ation was 49 mg for formulation 19 containing Tween 80 
(P < 0.05) and the minimum permeation was 15.3 mg for 
formulation 21 containing albumin (P < 0.05). According 
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Permeated AHA (mg) for formulations 1, 3, 5, 6, 8, 9, 11, 12, 13, 14, 15, and 17 
containing 2 mL of DW (no solvent), acetic acid (1 M), methanol, ethanol, 
isopropyl alcohol (IPA), glycerol, propylene glycol (PG), ethyl acetate (EA), 
tetrahydrofurane (THF), dimethyl sulfoxide (DMSO), liquid paraffin (LP), 
and olive oil, respectively (exposure time, 1.5 hours) (n = 3).




















Permeated AHA (mg) for formulations 18, 19, 20, and 21 containing 500 
mg of sodium lauryl sulfate (SLS), Tween 80, glycine, and albumin, respec-
tively (exposure time, 1.5 hours) (n = 3).



























Permeated AHA (mg) for formulations 2, 4, 7, 10, and 16 containing 6 mL 
of DW, acetic acid (1M), ethanol, glycerol, and liquid paraffin (LP), respec-
tively (exposure time, 12 hours) (n = 3).
to Figure 3, the permeation of AHA after 12 hours showed 
a maximum of 342.5 mg for formulation 16 (P < 0.05) and 
a minimum of 108.1 mg for formulation 4 (P < 0.05) con-
taining LP and acetic acid (1 M), respectively.
Figure 4. Permeated HA for Formulations 22, 24, 26, 27, 29, 30, 32, 33, 34, 


























Permeated HA (mg) for formulations 22, 24, 26, 27, 29, 30, 32, 33, 34, 35, 36, 
and 38 containing 2 mL of DW (no solvent), acetic acid (1 M), methanol, 
ethanol, isopropyl alcohol (IPA), glycerol, propylene glycol (PG), ethyl 
acetate (EA), tetrahydrofurane (THF), dimethyl sulfoxide (DMSO), liquid 
paraffin (LP), and olive oil, respectively (exposure time, 1.5 hours) (n = 3).
Figure 5. Permeated HA for Formulations 39, 40, 41, and 42


















Permeated HA (mg) for formulations 39, 40, 41, and 42 containing 500 mg 
of sodium lauryl sulfate (SLS), Tween 80, glycine, and albumin, respective-
ly (exposure time, 1.5 hours) (n = 3).






















Permeated HA (mg) for formulations 23, 25, 28, 31, and 37 containing 6 mL 
of DW, acetic acid (1M), ethanol, glycerol, and liquid paraffin (LP), respec-
tively (exposure time, 12 hours) (n = 3).
 Figures 4 to 6 show permeation of HA through the skin 
from different formulations. Figures 4 and 5 show perme-
ation of HA through the skin from different formulations 
after 1.5 hours, and Figure 6 shows similar data after 12 
hours. Using solvents as permeation enhancers (Figure 
4), the maximum permeation after 1.5 hours belonged to 
the formulations 30, 29, and 36 containing 2 mL of glyc-
erol (57.3), IPA (23.4), and LP (23.2), respectively (P < 0.05). 
The minimum permeation after 1.5 hours belonged to 
the formulation 34, 33, and 22 (each about 0.3 mg) (P < 
0.05) containing 2 mL of THF, EA, and DW, respectively 
(Figure 4). Other solvents lead to permeations between 
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these amounts with a maximum of about 11.5 mg (P < 
0.05). Using surfactants as permeation enhancers (Figure 
5), the maximum and minimum HA permeation were 8.1 
and 0.4 mg for formulation 40 (containing Tween 80; P < 
0.05) and 42 (containing albumin; P < 0.05), respective-
ly. Figure 6 presents permeated HA after 12 hours with a 
maximum of 70.6 mg for formulation 31 (P < 0.05) and 
a minimum of 18.7 mg for formulation 28 (P < 0.05) con-
taining glycerol and ethanol, respectively.
5. Discussion
Results presented in the previous section revealed that 
generally, the enhancers used in this study positively af-
fected the dermal permeation of both AHA and HA. Most 
of the enhancers increased the AHA permeation in com-
parison with that of formulation 1 (without enhancer). 
LP and glycerol strongly enhanced the AHA permeation, 
which would be due to the low volatility and strong sol-
vent characteristics for AHA. Therefore, they neither evapo-
rate nor dissolved the AHA, which led to the AHA transfer 
across the skin. On the other hand, they could dissolve the 
lipids of skin layers resulting in a decrease in the lipid vis-
cosity and therefore, enhanced AHA transfer through the 
skin. Although IPA and EA had strongly enhanced the AHA 
permeation, it was not as effective as LP and glycerol. In 
fact, although IPA and EA are almost volatile, they have the 
ability to dissolve both AHA and skin lipids. DMSO, THF, PG, 
ethanol, and olive oil moderately enhanced the AHA per-
meation. Most of these solvents can dissolve both hydro-
philic and hydrophobic substances and therefore, dissolve 
AHA and skin lipids. Since these solvents possess strong 
ability to dissolve hydrophobic substances, they also cre-
ate new pathways in skin layers for the transfer of AHA 
molecules. Among these solvents, olive oil showed weaker 
effects than others because of its disability to dissolve AHA. 
As the last group, acetic acid (1 M), DW, and methanol could 
weakly enhance the AHA permeation. Although they could 
dissolve AHA, they lacked the ability to dissolve skin lipids. 
Despite other solvents, methanol decreased the AHA per-
meation. Therefore, LP and glycerol were the most effec-
tive enhancers for AHA permeation to the skin. 
In case of using surfactants as enhancers, only Tween 
80 increased the AHA permeation. Glycine showed no 
change in AHA permeation, while SLS and albumin de-
creased the AHA permeation. Amphiphilic molecules of 
Tween 80 could deposit between amphiphilic molecules 
in the skin layers. Such a mechanism can disrupt the lipid 
structure of the skin and therefore, can enhance the AHA 
permeation. Glycine could not affect the permeation, 
because of its weak surfactant characteristic. In case of 
SLS, its molecules can form an impermeable complex 
with AHA molecules. This can be the reason that AHA per-
meation was less in the presence of SLS. Albumin with 
a much larger molecular weight than other enhancers 
could hardly pass the skin. Little amounts of penetrated 
albumin deposited in the skin layers and because of its 
large molecule, it inhibited the AHA permeation. There-
fore, Tween 80 was the most effective surfactant enhanc-
er for the AHA permeation. Increasing the used volume of 
each solvent including DW, acetic acid, ethanol, glycerol, 
and LP (formulations 2, 4, 7, 10, and 16, respectively) from 
2 to 6 mL, and prolonging the exposure time from 1.5 to 12 
hours resulted in dramatic improve in AHA permeation 
in comparison with those for same solvents with the vol-
ume of 2 mL and the exposure time of 1.5 hours. Such el-
evations in concentration and exposure time were more 
effective for LP and glycerol as well as DW, which gave the 
highest AHA permeations of 342.5, 315.5, and 298.2 mg, re-
spectively. Such a method of using the enhancer can be 
recommended when a long-term application of the for-
mulation is possible.
Okuda et al. reported that AHA did not considerably 
penetrate the human skin within one to three minutes. 
They used shampoos containing AHA followed by rins-
ing of the shampoo after one to three minutes. They con-
cluded that the main determinants of AHA penetration 
into the human skin were pH, concentration, and time 
(7). Our results confirm these findings since the primary 
concentration of AHA or HA and the exposure time in our 
study were respectively larger and longer than those of 
Okuda et al. (7). Most of the formulations increased the 
HA permeation in comparison with the formulation 22, 
which had no enhancer. EA, THF, albumin, and almost 
glycine (formulations 33, 34, 42, and 41, respectively) were 
the exceptions that did not increase the HA permeation. 
These effects were related to the volatility of EA and THF, 
high molecular weight of albumin, and weak surfactant 
characteristics of glycine. The solvents, glycerol, IPA, LP, 
and PG (formulations 30, 29, 36, and 32, respectively) con-
siderably enhanced the HA permeation. The reason was 
that they not only were good vehicles for HA molecules 
but also could strongly dissolve the skin lipids that led to 
decreased lipid viscosity and enhanced HA permeation. 
Considering such a mechanism, glycerol was the most 
potent solvent and enhancer for HA. Solvents including 
DMSO, methanol, acetic acid, olive oil, and ethanol as well 
as surfactants including SLS and Tween 80 moderately en-
hanced the HA permeation (formulations 35, 26, 24, 38, 27, 
39, and 40, respectively). DMSO is more volatile than oth-
ers and therefore, did not have enough time for its action. 
Methanol, acetic acid, and ethanol could dissolve both 
HA and skin lipids. Although olive oil did not dissolve 
the hydrophilic HA, it showed its potency to dissolve the 
skin lipids by its slight improvement in HA permeation. 
EA and THF enhanced the AHA permeation more than 
HA. This could be due to the small molecules of AHA were 
mixable with EA and THF that led to a slight decrease in 
EA and THF melting points and therefore, inhibited the 
rapid evaporation of EA and THF. This phenomenon gave 
the EA and THF enough time to act as enhancers. Gener-
ally, HA needed more time for permeation and also could 
not make a homogeneous solution or mixture with EA 
and THF. Therefore, EA and THF evaporated more rapidly 
witha lack of enough time for their enhancement action. 
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SLS and Tween 80, the well-known pharmaceutical sur-
factants, acted with the mechanism mentioned above for 
the permeation of AHA. The noticeable point was that the 
enhancing effect of SLS or Tween 80 for permeation of HA 
was significantly higher than that of AHA, which proved 
the more effectiveness of surfactants for permeation of 
larger molecules. Albumin and glycine did not enhance 
the HA permeation. Although peptide or protein struc-
tures are one group of surfactant compounds, this inef-
fectiveness was referred to the large molecular weight 
of albumin and weak surfactant structure of glycine. 
Since the molecular weight of HA was high, they needed 
enough space for passing the skin layers that was occu-
pied by the large molecules of albumin.
Similar to the results for AHA, increasing the volume of 
each solvent including DW, acetic acid, ethanol, glycerol, 
and LP (formulations 23, 25, 28, 31, and 37, respectively) 
from 2 mL to 6 mL, and prolonging their exposure time 
from 1.5 hours to 12 hours led to a dramatic improvement 
in HA permeation in comparison with those for same sol-
vents with the volume of 2 mL and exposure time of 1.5 
hours. Such increase in concentration and prolongation 
of exposure time were more effective for glycerol, acetic 
acid, and then for LP, which presented the largest perme-
ations of HA in this study with the average HA perme-
ations of 70.6, 34.1, and 31.8 mg, respectively. This method 
of using extended exposure times could be performed 
when the related formulation can be applied and remain 
on the skin for a long time. Overall, results showed that 
the enhancement of HA permeation was less than that of 
AHA. Since both molecules have hydrophilic structures, 
such results were attributed to the higher molecular 
weight of HA than AHA. 
There are several reports indicating the need for an en-
hancement mechanism to increase the permeation of HA 
through the skin. Yang et al. reported that considerable 
amount of HA could pass across mouse skin and enter the 
blood stream using its conjugation with human growth 
hormone (HA-hGH) via a receptor-mediated transdermal 
delivery method (8). Chen et al. also could deliver con-
siderable amount of HA through the porcine skin using 
skin permeating and cell entering (SPACE) peptide carri-
ers (2). Lim et al. synthesized HA and polyethylene glycol 
(PEG) hydrogel nanoparticles (37 nm) and used them as 
effective carriers in transdermal delivery systems. They 
obtained considerable nanoparticle penetration into a 
skin of albino guinea pig (9). All these researches sug-
gested ways for improvement of HA permeation. Our 
results presented another way for such improvement 
via using suitable solvents and surfactants. This recom-
mended way is significantly easier and more accessible 
for such a purpose, although it had slightly lower po-
tency than suggested ways in the aforementioned stud-
ies. Most of the transdermal absorption enhancers used 
in this study elevated the AHA or HA skin permeation. 
Negligible amounts of HA permeated the skin without 
any enhancer or in the presence of DW. Enhancers were 
more effective for HA than AHA. The most potent enhanc-
ers for increasing the permeation of AHA after 1.5 hours 
were LP, glycerol, and EA, consecutively, and the most 
potent enhancers for increasing the permeation of HA 
after 1.5 hours were glycerol, IPA, and LP, consecutively. 
Permeations were considerably improved by increas-
ing volume of enhancer and prolonging exposure time, 
which gave the maximum AHA or HA permeations in this 
study. The most potent enhancers for increasing the AHA 
permeation after 12 hours were LP, glycerol, and DW, con-
secutively, and the most potent enhancers for increasing 
the HA permeation after 12 hours were glycerol, acetic 
acid (1 M), and LP, consecutively. In this order, the maxi-
mum permeation of AHA was 342.5 mg obtained by the 
formulation containing 6 mL of LP with exposure time of 
12 hours. The maximum permeation of HA was 70.6 mg 
obtained by the formulation containing 6 mL of glycerol 
with exposure time of 12 hours. The effective enhancers 
for AHA permeation, which were also effective for HA 
permeation, were glycerol and LP either in short-term 
(1.5 hours) or in long-term use (12 hours). The latter en-
hancers are recommended for using in topical cosmetic 
or pharmaceutical products containing both AHA and 
HA. If surfactants are to be used in such products, Tween 
80, which was effective for increasing the permeation of 
both AHA and HA, is recommended. Ultimately, the use 
of albumin (or other proteins), methanol, or SLS in topi-
cal preparations containing AHA should be evaluated 
and optimized, because these enhancers decreased the 
amounts of permeated AHA.
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